Cargando…

The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer

BACKGROUND: Inflammation plays an important role in the pathogenesis of ovarian cancer. This study sought to investigate the association between the preoperative c-reactive protein/albumin ratio (CRP/Alb) and oncological outcomes in ovarian cancer patients. METHODS: Two hundred patients with histolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yubo, Chen, Shengfu, Zheng, Chengyu, Ding, Miao, Zhang, Lan, Wang, Liangan, Xie, Meiqing, Zhou, Jianhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399817/
https://www.ncbi.nlm.nih.gov/pubmed/28431566
http://dx.doi.org/10.1186/s12885-017-3220-x
_version_ 1783230711632756736
author Liu, Yubo
Chen, Shengfu
Zheng, Chengyu
Ding, Miao
Zhang, Lan
Wang, Liangan
Xie, Meiqing
Zhou, Jianhua
author_facet Liu, Yubo
Chen, Shengfu
Zheng, Chengyu
Ding, Miao
Zhang, Lan
Wang, Liangan
Xie, Meiqing
Zhou, Jianhua
author_sort Liu, Yubo
collection PubMed
description BACKGROUND: Inflammation plays an important role in the pathogenesis of ovarian cancer. This study sought to investigate the association between the preoperative c-reactive protein/albumin ratio (CRP/Alb) and oncological outcomes in ovarian cancer patients. METHODS: Two hundred patients with histologically verified ovarian cancer between June 2006 and July 2012 were retrospectively reviewed. Overall survival was evaluated by the Kaplan–Meier method and log-rank test. The significance of risk factors for overall survival was evaluated with the Cox proportional hazards model. Additionally, area under the receiver operating characteristic curve (AUC) was used to compare the predictive ability of CRP/Alb, Glasgow Prognostic Score (GPS), modified GPS (mGPS), neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), prognostic index (PI) and prognostic nutritional index (PNI). RESULTS: The optimal cutoff value of CRP/Alb was 0.68. Increased CRP/Alb (≥0.68) was associated with advanced stage, residual tumor, ascites, elevated serum carbohydrate antigen(CA)-125 level, GPS, and mGPS (all p < 0.05). Patients with high CRP/Alb had poor overall survival compared to those with low CRP/Alb (p < 0.001). Multivariable analysis showed that CRP/Alb (Hazard Ratio (HR) 1.330, 95% confidence interval (CI) 1.131–1.564, p = 0.001), tumor stage (HR 1.577, 95% CI 1.189–2.091, p = 0.002), residual tumor (HR 2.337, 95% CI 1.518–3.597, p < 0.001) and age (HR 1.017, 95% CI 1.000–1.035, p = 0.046) were independent prognostic factors for overall survival. Additionally, the CRP/Alb showed greater AUC values at 1 year (0.692), 3 years (0.659), and 5 years (0.682) than GPS, mGPS and PNI. CONCLUSIONS: The CRP/Alb is a novel independent marker of poor prognosis among ovarian cancer patients and shows superior prognostic ability compared to the established inflammation-based prognostic indices. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3220-x) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5399817
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-53998172017-04-24 The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer Liu, Yubo Chen, Shengfu Zheng, Chengyu Ding, Miao Zhang, Lan Wang, Liangan Xie, Meiqing Zhou, Jianhua BMC Cancer Research Article BACKGROUND: Inflammation plays an important role in the pathogenesis of ovarian cancer. This study sought to investigate the association between the preoperative c-reactive protein/albumin ratio (CRP/Alb) and oncological outcomes in ovarian cancer patients. METHODS: Two hundred patients with histologically verified ovarian cancer between June 2006 and July 2012 were retrospectively reviewed. Overall survival was evaluated by the Kaplan–Meier method and log-rank test. The significance of risk factors for overall survival was evaluated with the Cox proportional hazards model. Additionally, area under the receiver operating characteristic curve (AUC) was used to compare the predictive ability of CRP/Alb, Glasgow Prognostic Score (GPS), modified GPS (mGPS), neutrophil lymphocyte ratio (NLR), platelet lymphocyte ratio (PLR), prognostic index (PI) and prognostic nutritional index (PNI). RESULTS: The optimal cutoff value of CRP/Alb was 0.68. Increased CRP/Alb (≥0.68) was associated with advanced stage, residual tumor, ascites, elevated serum carbohydrate antigen(CA)-125 level, GPS, and mGPS (all p < 0.05). Patients with high CRP/Alb had poor overall survival compared to those with low CRP/Alb (p < 0.001). Multivariable analysis showed that CRP/Alb (Hazard Ratio (HR) 1.330, 95% confidence interval (CI) 1.131–1.564, p = 0.001), tumor stage (HR 1.577, 95% CI 1.189–2.091, p = 0.002), residual tumor (HR 2.337, 95% CI 1.518–3.597, p < 0.001) and age (HR 1.017, 95% CI 1.000–1.035, p = 0.046) were independent prognostic factors for overall survival. Additionally, the CRP/Alb showed greater AUC values at 1 year (0.692), 3 years (0.659), and 5 years (0.682) than GPS, mGPS and PNI. CONCLUSIONS: The CRP/Alb is a novel independent marker of poor prognosis among ovarian cancer patients and shows superior prognostic ability compared to the established inflammation-based prognostic indices. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-017-3220-x) contains supplementary material, which is available to authorized users. BioMed Central 2017-04-21 /pmc/articles/PMC5399817/ /pubmed/28431566 http://dx.doi.org/10.1186/s12885-017-3220-x Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Liu, Yubo
Chen, Shengfu
Zheng, Chengyu
Ding, Miao
Zhang, Lan
Wang, Liangan
Xie, Meiqing
Zhou, Jianhua
The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
title The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
title_full The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
title_fullStr The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
title_full_unstemmed The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
title_short The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
title_sort prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5399817/
https://www.ncbi.nlm.nih.gov/pubmed/28431566
http://dx.doi.org/10.1186/s12885-017-3220-x
work_keys_str_mv AT liuyubo theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT chenshengfu theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT zhengchengyu theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT dingmiao theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT zhanglan theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT wangliangan theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT xiemeiqing theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT zhoujianhua theprognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT liuyubo prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT chenshengfu prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT zhengchengyu prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT dingmiao prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT zhanglan prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT wangliangan prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT xiemeiqing prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer
AT zhoujianhua prognosticvalueofthepreoperativecreactiveproteinalbuminratioinovariancancer